Effect of Ozonated Gel Phonophoresis on Pain and Functional Disability in Patients With Chronic Supraspinatus Tendinitis
Not yet recruitingNot applicableNCT07316738
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study will be conducted to investigate the effect of ozonated gel phonophoresis on pain intensity, shoulder joint range of motion, and functional disability in patients with chronic supraspinatus tendinitis grades I and II.
Study details
- Official title
- Effect of Ozonated Gel Phonophoresis on Pain and Functional Disability in Patients With Chronic Supraspinatus Tendinitis
- Conditions
- Supraspinatus Tendinitis
- Interventions
- Other: ozonated gel phonophoresis
- Other: conventional treatment
- Sponsor
- Cairo University
- Start date
- 2025-12-25
- Primary completion
- 2026-02-25
- Sex
- All
- Age range
- from 30 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients from 30-60 years old from both genders. * The patients will be assigned to the study will be diagnosed with grade I or II supraspinatus tendinitis based on Neer's classification. * The patients suffered from supraspinatus tendinitis for more than 3 months and taking non-steroidal anti-inflammatory drugs suggested by orthopedist. * All patients have body mass index between 18.5 and 29.9 kg/m2. Exclusion Criteria: * Grades III of supraspinatus tendinitis. (Bone spurs and tendon rapture) * Any past shoulder surgical interventions. (Rotator cuff repair, labrum tear and open reduction internal fixation) * Shoulder joint instability * Shoulder fracture. * Non-cooperative subjects. * Neuromuscular diseases (spinal muscular atrophy, whiplash injury) * Cardiovascular disease. * History of cancer. * Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes. * Severe medical and neurological or psychiatric disorders. * Pregnant and lactating women.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07316738